ZA852370B - Antitumor antibiotic compound - Google Patents

Antitumor antibiotic compound

Info

Publication number
ZA852370B
ZA852370B ZA852370A ZA852370A ZA852370B ZA 852370 B ZA852370 B ZA 852370B ZA 852370 A ZA852370 A ZA 852370A ZA 852370 A ZA852370 A ZA 852370A ZA 852370 B ZA852370 B ZA 852370B
Authority
ZA
South Africa
Prior art keywords
antibiotic compound
antitumor antibiotic
antitumor
compound
antibiotic
Prior art date
Application number
ZA852370A
Other languages
English (en)
Inventor
James A Matson
James A Bush
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ZA852370B publication Critical patent/ZA852370B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/19—Antibiotic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
ZA852370A 1984-06-18 1985-03-28 Antitumor antibiotic compound ZA852370B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/621,641 US4582639A (en) 1984-06-18 1984-06-18 Antitumor antibiotic compound

Publications (1)

Publication Number Publication Date
ZA852370B true ZA852370B (en) 1985-11-27

Family

ID=24491001

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA852370A ZA852370B (en) 1984-06-18 1985-03-28 Antitumor antibiotic compound

Country Status (23)

Country Link
US (1) US4582639A (xx)
JP (1) JPS6122099A (xx)
KR (1) KR930003107B1 (xx)
AT (1) AT395860B (xx)
AU (1) AU584075B2 (xx)
BE (1) BE902670A (xx)
CA (1) CA1230568A (xx)
CH (1) CH668974A5 (xx)
DE (1) DE3521436A1 (xx)
DK (1) DK272985A (xx)
ES (1) ES8609485A1 (xx)
FI (1) FI80475C (xx)
FR (1) FR2568892B1 (xx)
GB (1) GB2160529B (xx)
GR (1) GR851452B (xx)
IE (1) IE58629B1 (xx)
IT (1) IT1191622B (xx)
LU (1) LU85953A1 (xx)
MY (1) MY100478A (xx)
NL (1) NL8501708A (xx)
PT (1) PT80656B (xx)
SE (1) SE464524B (xx)
ZA (1) ZA852370B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902781A (en) * 1987-11-24 1990-02-20 Taisho Pharmaceutical Co., Ltd. Novel tripetide derivatives
DE3832362A1 (de) * 1988-09-23 1990-03-29 Sandoz Ag Neue cyclopeptolide, verfahren zu ihrer herstellung und ihre verwendung
US5523219A (en) * 1993-06-15 1996-06-04 Bristol-Myers Squibb Company Enzymatic hydrolysis method for the preparation of C-10 hydroxyl-bearing taxanes and enzymatic esterification method for the preparation of C-10 acyloxy-bearing
US5516676A (en) * 1993-06-15 1996-05-14 Bristol-Myers Squibb Company Preparation of C-13 hydroxyl-bearing taxanes using nocardioides or a hydrolase isolated therefrom
US5643871A (en) * 1993-11-23 1997-07-01 Bristol-Meyers Squibb Company Antitumor antibiotics
US5444043A (en) * 1994-02-18 1995-08-22 The Regents Of The University Of California Cyclic heptapeptide anti-inflammatory agent
GB2294265A (en) * 1994-10-20 1996-04-24 Merck & Co Inc Cyclic depsipeptides obtained from Actinomycete sp.
US6329497B1 (en) * 1997-03-28 2001-12-11 The Scripps Research Institute Sandramycin analogs
US6001815A (en) * 1997-12-25 1999-12-14 Nisshin Flour Milling Co., Ltd. Depsipeptides containing N-substituted glycine residue
KR100575681B1 (ko) 2004-05-18 2006-05-03 엘지전자 주식회사 와인 냉장고의 진동절연 지지장치
EP1924245A2 (en) * 2005-08-19 2008-05-28 Government of the United States of America, Represented by the Secretary, Department of Health and Human Services Topical formulations of histone deacetylase inhibitors and methods of using the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4360458A (en) * 1979-04-02 1982-11-23 Bristol-Myers Company Antitumor antibacterial agents
US4451456A (en) * 1979-04-02 1984-05-29 Bristol-Myers Company Antitumor antibacterial agents

Also Published As

Publication number Publication date
ES8609485A1 (es) 1986-09-01
ATA178285A (de) 1992-08-15
AU4048085A (en) 1986-01-02
FR2568892B1 (fr) 1990-02-09
FI852082A0 (fi) 1985-05-24
IE58629B1 (en) 1993-10-20
IT8521156A0 (it) 1985-06-14
GB2160529B (en) 1987-10-07
JPS6122099A (ja) 1986-01-30
PT80656A (en) 1985-07-01
LU85953A1 (fr) 1986-01-24
KR930003107B1 (ko) 1993-04-19
DK272985D0 (da) 1985-06-17
FI80475C (fi) 1990-06-11
IE851504L (en) 1985-12-18
SE8502996D0 (sv) 1985-06-17
BE902670A (fr) 1985-12-17
US4582639A (en) 1986-04-15
KR860000382A (ko) 1986-01-28
DE3521436A1 (de) 1985-12-19
IT1191622B (it) 1988-03-23
CA1230568A (en) 1987-12-22
AT395860B (de) 1993-03-25
JPH0158200B2 (xx) 1989-12-11
SE8502996L (sv) 1985-12-19
SE464524B (sv) 1991-05-06
GB8515256D0 (en) 1985-07-17
GR851452B (xx) 1985-11-25
MY100478A (en) 1990-10-15
FR2568892A1 (fr) 1986-02-14
GB2160529A (en) 1985-12-24
NL8501708A (nl) 1986-01-16
CH668974A5 (de) 1989-02-15
FI80475B (fi) 1990-02-28
DK272985A (da) 1985-12-19
FI852082L (fi) 1985-12-19
ES544289A0 (es) 1986-09-01
PT80656B (pt) 1988-01-22
AU584075B2 (en) 1989-05-18
DE3521436C2 (xx) 1993-08-05

Similar Documents

Publication Publication Date Title
GB8522699D0 (en) Antibiotic compounds
GB8432368D0 (en) Antibiotic compound
GB8512334D0 (en) Antibiotic
GB2160529B (en) Antitumor antibiotic compound
GB8421279D0 (en) Antibiotics
GB8415093D0 (en) Antibiotic l 17392
EP0180399A3 (en) Anti-tumor 4-hydroxy-2-cyclopentenones
GB8507503D0 (en) Acetyl compound
GB8412368D0 (en) Antitumor antibiotic complex
GB2152028B (en) Antitumor antibiotic
AU585264B2 (en) Antibiotic A80190
GB2124234B (en) Antitumor antibiotic
GB8408292D0 (en) Quinolizinone compound
GB8405087D0 (en) Antibiotic
GB8432519D0 (en) Antibiotic compounds
GB8507710D0 (en) Acetyl compound
GB8423278D0 (en) Antibiotic compounds
IE842100L (en) Antibiotic compound
IL93418A (en) Antitumor antibiotics ll-e33288alpha-i
GB2132604B (en) Antitumor antibiotic awamycin
IE842333L (en) Albicidin-an antibiotic
IE843191L (en) Antibiotic a52688
IL76607A0 (en) Antibiotic a80190
ZA857715B (en) Antibiotic a80190
GB8508728D0 (en) Antibiotic compound